Effects of the 5-HT1 receptor agonists, sumatriptan and CP 93,129, on dural arterial flow in the rat

European Journal of Pharmacology

Volumn 332, Issue 2, 1997, Pages 173-181

  Messlinger, Karl ^a   Hotta, Harumi ^b   Pawlak, Matthias ^a   Schmidt, Robert F ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

5 HT1 receptor agonist; Arterial blood flow; Dura mater encephali; Headache; Migraine; Neurogenic inflammation; Rat

Indexed keywords

3 (1,2,5,6 TETRAHYDRO 4 PYRIDYL)PYRROLO[3,2 B]PYRIDIN 5 ONE; SEROTONIN 1 ANTAGONIST; SUMATRIPTAN SUCCINATE; 3 (1,2,5,6 TETRAHYDROPYRID 4 YL)PYRROLO(3,2 B)PYRID 5 ONE; 3-(1,2,5,6-TETRAHYDROPYRID-4-YL)PYRROLO(3,2-B)PYRID-5-ONE; PYRIDINE DERIVATIVE; PYRROLE DERIVATIVE; SEROTONIN AGONIST; SUMATRIPTAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY BLOOD FLOW; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DURA MATER; INTRAVENOUS DRUG ADMINISTRATION; LASER DOPPLER FLOWMETRY; MALE; MENINGEAL ARTERY; MIGRAINE; NONHUMAN; PRIORITY JOURNAL; RAT; TOPICAL DRUG ADMINISTRATION; ANIMAL; BRAIN CIRCULATION; TRIGEMINUS GANGLION; VASCULARIZATION; WISTAR RAT;

ANIMALS; CEREBROVASCULAR CIRCULATION; DURA MATER; MALE; MENINGEAL ARTERIES; PYRIDINES; PYRROLES; RATS; RATS, WISTAR; SEROTONIN AGONISTS; SUMATRIPTAN; TRIGEMINAL GANGLION;

EID: 0030612512     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01072-8     Document Type: Article

References (60)

1. Basbaum, A.I., Levine, J.D., 1991. The contribution of the nervous system to inflammation and inflammatory disease. Can. J. Physiol. Pharmacol. 69, 647-651.
2. Brändli, P., Löffler, B.-M., Breu, V., Osterwalder, R., Maire, J.-P., Clozel, M., 1995. Role of endothelin in mediating neurogenic plasma extravasation in rat dura mater. Pain 64, 315-322.
3. Buzzi, M.G., Moskowitz, M.A., 1990. The antimigraine drug, sumatriptan (GR 43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater. Br. J. Pharmacol. 99, 202-206.
4. Buzzi, M.G., Carter, W.B., Shimizu, T., Heath, H.G., Moskowitz, M.A., 1991a. Dihydroergotamine and sumatriptan attenuate levels of CGRP in plasma in rat superior sagittal sinus during electrical stimulation of the trigeminal ganglion. Neuropharmacology 30, 1193-1200.
5. Buzzi, M.G., Moskowitz, M.A., Peroutka, S.J., Byun, B., 1991b. Further characterization of the putative 5-HT receptor which mediates blockade of neurogenic plasma extravasation in rat dura mater. Br. J. Pharmacol. 103, 1421-1428.
6. Buzzi, M.G., Dimitriadou, V., Theoharides, T.C., Moskowitz, M.A., 1992. 5-Hydroxytryptamine receptor agonists for the abortive treatment of vascular headaches block mast cell, endothelial and platelet activation within the rat dura mater after trigeminal stimulation. Brain Res. 583, 137-149.
7. Carmody, J., Pawlak, M., Messlinger, K., 1996. Lack of a role for substance P in the control of dural arterial flow. Exp. Brain. Res. 111, 424-428.
8. 1-like receptor agonist, on pial vessel diameter in anaesthetised cats. J. Cereb. Blood Flow Metab. 12, 514-519.
9. Den Boer, M.O., Somers, J.A.E., Saxena, P.R., 1992. Lack of effect of the antimigraine drugs, sumatriptan, ergotamine and dihydroergotamine on arteriovenous anastomotic shunting in the dura mater of the pig. Br. J. Pharmacol. 107, 577-583.
10. Dimitriadou, V., Buzzi, M.G., Moskowitz, M.A., Theoharides, T.C., 1991. Trigeminal sensory fiber stimulation induces morphological changes reflecting secretion in rat dura mater mast cells. Neuroscience 44, 97-112.
11. Dimitriadou, V., Buzzi, M.G., Theoharides, T.C., Moskowitz, M.A., 1992. Ultrastructural evidence for neurogenically mediated changes in blood vessels of the rat dura mater and tongue following antidromic trigeminal stimulation. Neuroscience 48, 187-203.
12. Dimlich, R.V.W., Keller, J.T., Strauss, T.A., Fritts, M.J., 1991. Linear arrays of homogenous mast cells in the dura mater of the rat. J. Neurocytol. 20, 485-503.
13. Donnerer, J., Amann, R., 1993. The inhibition of neurogenic inflammation. Gen. Pharmacol. 24, 519-529.
14. Drummond, P.D., Lance, J.W., 1983. Extracranial vascular changes and the source of pain in migraine headache. Ann. Neurol. 13, 32-37.
15. Edvinsson, L., Cervós-Navarro, J., Larsson, L.-I., Owman, C., Rönnberg, A.-L., 1977. Regional distribution of mast cells containing histamine, dopamine, or 5-hydroxytryptamine in the mammalian brain. Neurology 27, 878-883.
16. Edvinsson, L., Rosendal-Helgesen, S., Uddman, R., 1983. Substance P: Localization, concentration and release in cerebral arteries, choroid plexus and dura mater. Cell Tissue Res. 234, 1-7.
17. Edvinsson, L., Ekman, R., Jansen, I., McCulloch, J., Uddman, R., 1987. Calcitonin gene-related peptide and cerebral blood vessels: Distribution and vasomotor effects. J. Cereb. Blood Flow Metab. 7, 720-728.
18. Escott, K.J., Beattie, D.T., Connor, H.E., Brain, S.D., 1995. Trigeminal ganglion stimulation increases facial skin blood flow in the rat: A major role for calcitonin gene-related peptide. Brain Res. 669, 93-99.
19. Ferrari, M.D., 1993. Sumatriptan in the treatment of migraine. Neurology 43, S43-S47.
20. 1 receptors in migraine pathophysiology and treatment. Eur. J. Neurol. 2, 5-21.
21. Friberg, L., Olesen, J., Iversen, H.K., Sperling, B., 1991. Migraine pain associated with middle cerebral dilatation: Reversal by sumatriptan. Lancet 338, 13-17.
22. Goadsby, P.J., Edvinsson, L., 1993. The trigeminovascular system and migraine: Studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann. Neurol. 33, 48-56.
23. Goadsby, P.J., Edvinsson, L., 1994a. Peripheral and central trigeminovascular activation in cat is blocked by the serotonin (5HT)-1D receptor agonist 311C90. Headache 34, 394-399.
24. Goadsby, P.J., Edvinsson, L., 1994b. Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies. Brain 117, 427-434.
25. Goadsby, P.J., Edvinsson, L., Ekman, R., 1988. Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system. Ann. Neurol. 23, 193-196.
26. Goadsby, P.J., Edvinsson, L., Ekman, R., 1990. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann. Neurol. 28, 183-187.
27. Hardebo, J.E., 1990. On pain mechanisms in cluster headache. Headache 31, 91-106.
28. Hartig, P.R., Hoyer, D., Humphrey, P.P.A., Martin, G.R., 1996. Alignment of receptor nomenclature with the human genome: Classification of 5-HT1B and 5-HT1D receptor subtypes. Trends Pharmacol. Sci. 17, 103-105.
29. Henkes, H., May, A., Kühne, D., Berg-Dammer, E., Diener, H.C., 1996. Sumatriptan: Vasoactive effect on human dural vessels, demonstrated by subselective angiography. Cephalalgia 16, 224-230.
30. 1B/D agonists and endopeptidase 24.11. Br. J. Pharmacol. 108, 331-335.
31. Humphrey, P.P.A., Goadsby, P.J., 1994. The mode of action of sumatriptan is vascular? A debate. Cephalalgia 14, 401-410.
32. 1-like receptor in dog isolated saphenous vein. Br. J. Pharmacol. 94, 1123-1132.
33. Jansen, I., Uddman, R., Ekman, R., Olesen, J., Ottosson, A., Edvinsson, L., 1992. Distribution and effects of neuropeptide Y, vasoactive intestinal peptide, substance P, and calcitonin gene-related peptide in human middle meningeal arteries: Comparison with cerebral and temporal arteries. Peptides 13, 527-536.
34. Jansen, I., Olesen, J., Edvinsson, L., 1993. 5-Hydroxytryptamine receptor characterization of human cerebral, middle meningeal and temporal arteries: Regional differences. Acta Physiol. Scand. 147, 141-150.
35. Kaube, H., Hoskin, K.L., Goadsby, P.J., 1993. Inhibition by sumatriptan of central trigeminal neurones only after blood-brain barrier disruption. Br. J. Pharmacol. 109, 788-792.
36. Keller, J.T., Marfurt, C.F., 1991. Peptidergic and serotoninergic innervation of the rat dura mater. J. Comp. Neurol. 309, 515-534.
37. Knyihar-Csillik, E., Tajti, J., Mohtasham, S., Sari, G., Vecsei, L., 1995. Electrical stimulation of the Gasserian ganglion induces structural alterations of calcitonin gene-related peptide-immunoreactive perivascular sensory nerve terminals in the rat cerebral dura mater: A possible model of migraine headache. Neurosci. Lett. 184, 189-192.
38. Kurosawa, M., Messlinger, K., Pawlak, M., Schmidt, R.F., 1995. Increase of meningeal blood flow after electrical stimulation of rat dura mater encephali: Mediation by calcitonin gene-related peptide. Br. J. Pharmacol. 114, 1397-1402.
39. Lambert, G., Michalicek, J., 1996. Effect of antimigraine drugs on dural blood flows and resistances and the responses to trigeminal stimulation. Eur. J. Pharmacol. 311, 141-151.
40. Markowitz, S., Saito, K., Moskowitz, M.A., 1987. Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain. J. Neurosci. 7, 4129-4136.
41. 1B receptor agonist blocks neurogenic plasma extravasation within rat but not guinea-pig dura mater. Br. J. Pharmacol. 104, 3-4.
42. May, A., Gijsman, H.J., Wallnöfer, A., Jones, R., Diener, H.C., Ferrari, M.D., 1996. Endothelin antagonist blocks neurogenic inflammation, but is not effective in aborting migraine attacks. Pain 67, 375-378.
43. Messlinger, K., Hanesch, U., Baumgärtel, M., Trost, B., Schmidt, R.F., 1993. Innervation of the dura mater encephali of cat and rat: Ultra-structure and calcitonin gene-related peptide-like and substance P-like immunoreactivity. Anat. Embryol. 188, 219-237.
44. Messlinger, K., Hanesch, U., Kurosawa, M., Pawlak, M., Schmidt, R.F., 1995a. Calcitonin gene-related peptide released from dural nerve fibers mediates increase of meningeal blood flow in the rat. Can. J. Physiol. Pharmacol. 73, 1020-1024.
45. Messlinger, K., Ebersberger, A., Pawlak, M., Schepelmann, K., Schmidt, R.F., 1995b. Activation of meningeal afferents in the rat: Responses of trigeminal brain stem neurons and dural arterial flow. Soc. Neurosci. Abstr. 21, 1159.
46. Moskowitz, M.A., 1993. Neurogenic inflammation in the pathophysiology and treatment of migraine. Neurology 43, S16-S20.
47. Moskowitz, M.A., 1994. Drug mechanisms in acute migraine. In: Gebhart, D.L., Hammond, D.L., Jensen, T.S. (Eds.), Proceedings of the 7th World Congress on Pain, Progress in Pain Research and Management, vol. 2. IASP Press, Seattle, WA, pp. 755-764.
48. Moskowitz, M.A., Cutrer, F.M., 1994. Possible importance of neurogenic inflammation within the meninges to migraine headache. In: Fields, H.L., Liebeskind, J.C. (Eds.), Progress in Pain Research and Management, vol. 1. IASP Press, Seattle, pp. 43-49.
49. 1 receptor antagonist, RP 67580. Eur. J. Pharmacol. 238, 421-424.
50. Nozaki, K., Moskowitz, M.A., Boccalini, P., 1992. CP-93, 129, sumatriptan, dihydroergotamine block c-fos expression within rat trigeminal nucleus caudalis caused by chemical stimulation of the meninges. Br. J. Pharmacol. 106, 409-415.
51. O'Connor, T.P., Van der Kooy, D., 1988. Enrichment of a vasoactive neuropeptide (calcitonin gene related peptide) in the trigeminal sensory projection to the intracranial arteries. J. Neurosci. 8, 2468-2476.
52. Olesen, J., Friberg, L., Olsen, T.S., Iversen, H.K., Lassen, N.A., Andersen, A.R., Karle, A., 1990. Timing and topography of cerebral blood flow, aura, and headache during migraine attacks. Ann. Neurol. 28, 791-798.
53. 1 receptors mediate plasma protein extravasation in guinea-pig dura. Eur. J. Pharmacol. 236, 319-321.
54. 1Dα serotonin receptor gene expression in trigeminal ganglia: Implications for antimigraine drug development. Proc. Natl. Acad. Sci. USA 91, 3666-3669.
55. Saito, K., Markowitz, S., Moskowitz, M.A., 1988. Ergot alkaloids block neurogenic extravasation in dura mater: Proposed action in vascular headaches. Ann. Neurol. 24, 732-737.
56. Saxena, P.R., Tfelt-Hansen, P., 1993. Sumatriptan. In: Olesen, J., Tfelt-Hansen, P., Welch, K.M.A. (Eds.), The Headaches. Raven Press, New York, NY, pp. 329-341.
57. Shepheard, S.L., Williamson, D.J., Williams, J., Hill, R.G., Hargreaves, R.J., 1995. Comparison of the effects of sumatriptan and the NK1 antagonist CP-99,994 on plasma extravasation in dura mater and c-fos mRNA expression in trigeminal nucleus caudalis of rats. Neuropharmacology 34, 255-261.
58. Von During, M., Bauersachs, M., Böhmer, B., Veh, R.W., Andres, K.H., 1990. Neuropeptide Y- and substance P-like immunoreactive nerve fibers in the rat dura mater encephali. Anat. Embryol. 182, 363-373.
59. Wilkinson, M., Pfaffenrath, V., Schoenen, J., Diener, H.C., Steiner, T.J., 1995. Migraine and cluster headache - Their management with sumatriptan - A critical review of the current clinical experience. Cephalalgia 15, 337-357.
60. Zagami, A.S., Goadsby, P.J., Edvinsson, L., 1990. Stimulation of the superior sagittal sinus in the cat causes release of vasoactive peptides. Neuropeptides 16, 69-75.